|
Market Closed -
Nyse
21:00:02 23/01/2026 GMT
|
5-day change
|
1st Jan Change
|
|
54.65 USD
|
-0.53%
|
 |
-1.10%
|
+1.32%
|
|
01-12 |
BioXcel Therapeutics, Inc. Appoints Mark Pavao as Acting Chief Commercial Officer and Will Lead the Development and Execution of the Company's Commercial Plans
|
CI
| |
01-12 |
Zymeworks Inc. Announces Management Changes
|
CI
| |
01-07 |
Mediar Therapeutics, Inc. announced that it has received $76 million in funding from Amplitude Ventures Inc., ICG America, Inc., Longwood Fund, Asahi Kasei Pharma America Corporation, Alexandria Real Estate Equities, Inc.
|
CI
| |
12-16 |
KORU Medical Systems, Inc. Appoints Eric Schiller As Chief Technology Officer, Effective December 29, 2025
|
CI
| |
12-15 |
ImmunityBio, Inc. Appoints Bruce Wendel to the Board, Effective December 12, 2025
|
CI
| |
11-17 |
Mesoblast Appoints James O'Brien CFO
|
MT
| |
11-02 |
DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial, Effective November 3, 2025
|
CI
| |
04/09/25 |
Bristol Myers Squibb Insider Sold Shares Worth $2,650,480, According to a Recent SEC Filing
|
MT
| |
01/08/25 |
Turning point year for Clever Culture Systems
|
FI
| |
29/07/25 |
PRESS DIGEST-Wall Street Journal - July 29
|
RE
| |
25/07/25 |
Bristol-Myers Squibb Names Cristian Massacesi as Chief Medical Officer
|
MT
| |
25/07/25 |
Bristol Myers Squibb Announces Management Changes
|
CI
| |
13/05/25 |
Syndax Pharmaceuticals Appoints Nicholas Botwood Chief Medical Officer
|
MT
| |
06/05/25 |
Bristol Myers Squibb Announces Executive Changes
|
CI
| |
21/04/25 |
Zymeworks Inc. Announces Appointment of Sabeen Mekan, M.D., as Senior Vice President, Clinical Development
|
CI
| |
07/03/25 |
Novartis AG Approves Board Changes
|
CI
| |
18/02/25 |
Bristol-Myers Squibb Company Announces Retirement of Sandra Leung as Executive Vice President, General Counsel
|
CI
| |
15/01/25 |
Verastem Oncology Appoints Matthew E. Ros as Chief Operating Officer
|
CI
| |
10/01/25 |
Annexon, Inc. Appoints William ?BJ? Jones to Its Board of Directors
|
CI
| |
02/01/25 |
Lexicon Pharmaceuticals, Inc. Appoints Scott M. Coiante as Senior Vice President
|
CI
| |
08/10/24 |
CytoDyn Appoints Max Lataillade as Senior Vice President and Head of Clinical Development
|
CI
| |
07/10/24 |
Inozyme Pharma, Inc. Announces Appointment of Erik Harris to its Board of Directors
|
CI
| |
23/09/24 |
Acadia Pharmaceuticals Appoints Catherine Adams as CEO
|
MT
| |
18/09/24 |
Lincoln Financial Reports Passing of Board Member Michael F. Mee
|
CI
| |
24/07/24 |
Engene Holdings Inc. Announces Appointment of Ron Cooper as Chief Executive Officer
|
CI
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
